2001
DOI: 10.1016/s0264-410x(00)00502-8
|View full text |Cite
|
Sign up to set email alerts
|

Recombinant attenuated bacteria for the delivery of subunit vaccines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
34
0

Year Published

2002
2002
2012
2012

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 63 publications
(34 citation statements)
references
References 33 publications
0
34
0
Order By: Relevance
“…Lm is also capable of invading epithelial cells by a trigger mechanism using inl gene products. Therefore, Lm can be used as a vector to deliver cDNA into mammalian cells of both phagocytic and nonphagocytic cells, and this is demonstrated using cultured cells by in vitro infection (5,8).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Lm is also capable of invading epithelial cells by a trigger mechanism using inl gene products. Therefore, Lm can be used as a vector to deliver cDNA into mammalian cells of both phagocytic and nonphagocytic cells, and this is demonstrated using cultured cells by in vitro infection (5,8).…”
Section: Discussionmentioning
confidence: 99%
“…Based on the aforementioned observations, we concluded that the intracellular pathogen Lm functions as an immune response modulator and also as a good candidate for a vector to deliver a gene into mammalian cells to modulate the acquired immune response (5,8,29). We constructed the plasmid for gene transfer into mammalian cells using Lm as described in "Materials and Methods" (Fig.…”
Section: The Gene Manipulated Lm Function To Deliver a Gene Into Mammmentioning
confidence: 99%
“…DC were shown to phagocytose a variety of bacterial pathogens, including Mycobacterium tuberculosis (16), Listeria monocytogenes (13,21), Salmonella enterica serovar Typhimurium (8,39), Escherichia coli (31), Yersinia pseudotuberculosis (8), Shigella flexneri (8), Borrelia burgdorferi (10), and Streptococcus gordonii (5), and we recently reported the phagocytosis of N. (22). In most cases, the phagocytosed bacteria were found to be rapidly killed by the DC.…”
Section: Discussionmentioning
confidence: 99%
“…They may include improvement of the current inactivated polio vaccine by making it more efficacious in tropical countries and reducing its cost, as well as exploring entirely new approaches. These might include the development of a polio vaccine based on nonpathogenic enteric bacteria expressing engineered surface or secretable antigens or harboring viral cDNA (12,14,20,31). Hopefully, such a vaccine may turn out to be safe, inexpensive, and effective.…”
Section: Vol 77 2003 a Local Cessation Of Vaccination Against Poliomentioning
confidence: 99%